151 related articles for article (PubMed ID: 27583420)
1. Second-Generation H1-Antihistamines for Chronic Spontaneous Urticaria.
Saguil A; Mercado M
Am Fam Physician; 2016 Sep; 94(5):352-3. PubMed ID: 27583420
[No Abstract] [Full Text] [Related]
2. Second-generation H1-antihistamines in chronic urticaria: an evidence-based review.
Kavosh ER; Khan DA
Am J Clin Dermatol; 2011 Dec; 12(6):361-76. PubMed ID: 21967114
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.
Zuberbier T
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):9-18. PubMed ID: 21797930
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy of olopatadine and fexofenadine in chronic idiopathic urticaria patients: a crossover study.
Tanizaki H; Yamamoto Y; Nakamizo S; Otsuka A; Miyachi Y; Kabashima K
Pharmacology; 2015; 95(1-2):32-5. PubMed ID: 25592003
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing?
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
J Investig Allergol Clin Immunol; 2013; 23(3):141-4; quiz 2 p preceding 145. PubMed ID: 23967751
[TBL] [Abstract][Full Text] [Related]
6. Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
Belsito DV
J Drugs Dermatol; 2010 May; 9(5):503-12. PubMed ID: 20480793
[TBL] [Abstract][Full Text] [Related]
7. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
Yagami A; Furue M; Togawa M; Saito A; Hide M
J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
[TBL] [Abstract][Full Text] [Related]
8. Nonsedating antihistamines in the treatment of severe chronic idiopathic urticaria: are they used optimally?
Cheung ST; Tucker W
Br J Dermatol; 2006 May; 154(5):1012-3. PubMed ID: 16634919
[No Abstract] [Full Text] [Related]
9. Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria.
Nettis E; Cegolon L; Macchia L; Zaza I; Calogiuri G; Di Leo E
Acta Derm Venereol; 2018 Apr; 98(4):446-448. PubMed ID: 29362811
[No Abstract] [Full Text] [Related]
10. Chronic urticaria--assessment and treatment.
Fernando S; Broadfoot A
Aust Fam Physician; 2010 Mar; 39(3):135-8. PubMed ID: 20369115
[TBL] [Abstract][Full Text] [Related]
11. Treatment of refractory chronic urticaria: current and future therapeutic options.
Asero R; Tedeschi A; Cugno M
Am J Clin Dermatol; 2013 Dec; 14(6):481-8. PubMed ID: 24085572
[TBL] [Abstract][Full Text] [Related]
12. Antihistamines in the treatment of chronic urticaria.
Jáuregui I; Ferrer M; Montoro J; Dávila I; Bartra J; del Cuvillo A; Mullol J; Sastre J; Valero A
J Investig Allergol Clin Immunol; 2007; 17 Suppl 2():41-52. PubMed ID: 18228682
[TBL] [Abstract][Full Text] [Related]
13. Assessing the therapeutic benefits of antihistamines for the treatment of chronic idiopathic urticaria--a requirement for well-designed comparative clinical studies.
Dhar S; Varghese ST; Georges G
J Dermatolog Treat; 2005 Aug; 16(3):176-7. PubMed ID: 16096186
[No Abstract] [Full Text] [Related]
14. Risk factors of uncontrolled symptoms using the standard dose of second-generation H1 -antihistamines in chronic spontaneous urticaria children.
Koosakulchai V; Yuenyongviwat A; Sangsupawanich P
Asian Pac J Allergy Immunol; 2022 Jun; 40(2):121-125. PubMed ID: 32061244
[TBL] [Abstract][Full Text] [Related]
15. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.
Weller K; Ardelean E; Scholz E; Martus P; Zuberbier T; Maurer M
Acta Derm Venereol; 2013 Mar; 93(2):168-74. PubMed ID: 23053062
[TBL] [Abstract][Full Text] [Related]
16. Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients.
Kameyoshi Y; Tanaka T; Mihara S; Takahagi S; Niimi N; Hide M
Br J Dermatol; 2007 Oct; 157(4):803-4. PubMed ID: 17627798
[No Abstract] [Full Text] [Related]
17. Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
Yan S; Chen W; Wen S; Zhu W; Guo A; Chen X; Zhang C; Chen M; Zhang J; Su J; Zhao Y; He Y; Liu Z; Zhou H; Zeng W; Li J; Chen X
J Dermatol Sci; 2014 Dec; 76(3):240-5. PubMed ID: 25455139
[TBL] [Abstract][Full Text] [Related]
18. Urticaria and its subtypes: the role of second-generation antihistamines.
Ortonne JP
Eur J Intern Med; 2012 Jan; 23(1):26-30. PubMed ID: 22153526
[TBL] [Abstract][Full Text] [Related]
19. Long-term combinations and updosing of second-generation H
Zhang L; Wu J; Qi Y; Zhu H; Yao X; Li M; Li J; Guo Z; Su X; Lai W; Hao S; Li Y; Li Y; Yao C; Li F; Wang H; Liu Q; Long H; Lu Q; Gao X; Chen H; Xiao T
J Allergy Clin Immunol Pract; 2020 May; 8(5):1733-1736.e11. PubMed ID: 31857265
[No Abstract] [Full Text] [Related]
20. Review of H1 antihistamines in the treatment of chronic idiopathic urticaria.
Monroe E
Cutis; 2005 Aug; 76(2):118-26. PubMed ID: 16209158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
